The Usefulness of a Percutaneous Cardiopulmonary Support Device for the Treatment of Fulminant Myocarditis
![]() |
Lim, Juyoug
(Department of Thoracic and Cardiovascular Sugery, Seoul Asan Hospital, University of Ulsan College of Medicine)
Jung, Sung Ho (Department of Thoracic and Cardiovascular Sugery, Seoul Asan Hospital, University of Ulsan College of Medicine) Je, Hyoung-Gon (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Pusan National University College of Medicine) Lee, Taek Yeon (Department of Thoracic and Cardiovascular Sugery, Seoul Asan Hospital, University of Ulsan College of Medicine) Choo, Suk Jung (Department of Thoracic and Cardiovascular Sugery, Seoul Asan Hospital, University of Ulsan College of Medicine) Lee, Jae Won (Department of Thoracic and Cardiovascular Sugery, Seoul Asan Hospital, University of Ulsan College of Medicine) Chung, Cheol Hyun (Department of Thoracic and Cardiovascular Sugery, Seoul Asan Hospital, University of Ulsan College of Medicine) |
1 | Kang SK, Park SS, Na MH, et al. Management of acute fulminant myocarditis using a left ventricular assist device; a case report. Korean J Thorac Cardiovasc Surg 2001;34:490-3 |
2 | Maejima Y, Yasu T, Kubo N, et al. Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device. Circ J 2004;68:829-33 DOI ScienceOn |
3 | Kawahito K, Murata S, Yasu T, et al. Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse. Am J Cardiol 1998;82:910-1 DOI PUBMED ScienceOn |
4 | Kato S, Morimoto S, Hiramitsu S, Nomura M, Ito I, Hishida H. Use of percutaneous cardiopulmonary support with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol 1999;83:623-5 DOI ScienceOn |
5 | Chen YS, Yu HY, Huang SC, et al. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: What mechanical support should be considered first? J Heart Lung Transplant 2005;24:81-7 DOI ScienceOn |
6 | Aoyama N, Izumi T, Hiramori K, et al. National survey of fulminant myocarditis in Japan: Therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis: Special report from a scientific committee. Circ J 2002;66:133-44 DOI ScienceOn |
7 | Rockman HA, Adamson RM, Dembitsky WP, Bonar JW, Jaski BE. Acute fulminant myocarditis: Long-term follow up after circulatory support with left ventricular assist device. Am Heart J 1991;121:922-6 DOI ScienceOn |
8 | Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991;18:1617-26 DOI PUBMED |
9 | Martin J, Sarai K, Schindler M, Van de Loo A, Yoshitake M, Beyersdorf F. MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis. Ann Thorac Surg 1997;63:1145-6 DOI ScienceOn |
10 | Frexia X, Sionis A, Castel A, et al. Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis. Transplant Proc 2009;41:2234-6 DOI ScienceOn |
11 | Leprince P, Combes A, Nicolas B, et al. Circulatory support for fulminant myocarditis consideration for implantation, weaning and explantation. Eur J Cardiothorac Surg 2003;24:399-403 DOI ScienceOn |
12 | McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute(non-fulminant) myocarditis. N Engl J Med 2000;342:690-5 DOI ScienceOn |
13 | Eriksson S, Halenius H, Pulkki H, et al. Negative interferences in cardiac troponin I immunoassays by circulating troponin auto-antibodies. Clin Chem 2005;51:839 DOI ScienceOn |
14 | Chen YS, Ko WJ, Lin FY, et al. Preliminary result of an algorithm to select proper ventricular assist device for highrisk patients with extracorporeal membrane oxygenation support. J Heart Lung Transplant 2001;20:850-7 DOI ScienceOn |
![]() |